Vitro Diagnostics (VODG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2024 | 10-2023 | 10-2022 | 10-2021 | 10-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,874 | -5,357 | -6,860 | -4,522 | -1,563 |
| Depreciation Amortization | 4,327 | 398 | 351 | 353 | 305 |
| Accounts receivable | -87 | -46 | 44 | 15 | 9 |
| Accounts payable and accrued liabilities | -125 | 640 | 237 | -19 | 27 |
| Other Working Capital | 528 | 1,415 | 475 | 1,002 | 147 |
| Other Operating Activity | 1,994 | 981 | 3,537 | 2,173 | 295 |
| Operating Cash Flow | $-3,236 | $-1,969 | $-2,217 | $-998 | $-780 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -122 | -310 | -25 | -25 |
| Net Acquisitions | N/A | N/A | N/A | 370 | N/A |
| Purchase Sale Intangibles | -7 | -74 | N/A | -8 | N/A |
| Other Investing Activity | -7 | -74 | 0 | -8 | 0 |
| Investing Cash Flow | $-7 | $-195 | $-310 | $337 | $-25 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,775 | 1,718 | 200 | 3,000 | N/A |
| Debt Repayment | -62 | -63 | -76 | -49 | -41 |
| Other Financing Activity | 0 | -130 | -1,233 | 1,790 | 1,025 |
| Financing Cash Flow | $3,713 | $1,525 | $-1,109 | $4,741 | $984 |
| Beginning Cash Position | 102 | 742 | 4,377 | 297 | 119 |
| End Cash Position | 571 | 102 | 742 | 4,377 | 297 |
| Net Cash Flow | $470 | $-640 | $-3,635 | $4,080 | $179 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,236 | -1,969 | -2,217 | -998 | -780 |
| Capital Expenditure | N/A | -122 | -310 | -25 | -25 |
| Free Cash Flow | -3,236 | -2,090 | -2,527 | -1,023 | -805 |